Nektar Therapeutics | NKTR - Cost Of Sales


Nektar Therapeutics reported $4.43M in Cost of Sales for its fiscal quarter ending in September of 2024.





Cost Of Sales Change Date
Agios Pharmaceuticals USD 1.88M 199K Dec/2025
ALKERMES USD 46.21M 5.38M Dec/2025
Amgen USD 1.79B 128M Dec/2025
Baxter International USD 2.4B 512M Dec/2025
BioCryst Pharmaceuticals USD 12.27M 9.04M Dec/2024
Biogen USD 810.1M 205.1M Sep/2025
Bristol-Myers Squibb USD 4.92B 657M Dec/2025
Cara Therapeutics USD 0 0 Mar/2025
Cipla INR 29.1B 1.16B Dec/2025
Dr.Reddys Laboratories INR 36.16B 3.75B Dec/2025
Eisai JPY 51.08B 5.56B Dec/2025
Eli Lilly USD 3.37B 363.7M Dec/2025
Esperion Therapeutics USD 51.63M 22.2M Sep/2024
Exelixis USD 26.48M 7.91M Dec/2025
Gilead Sciences USD 1.62B 50M Dec/2025
GlaxoSmithKline GBP 2.61B 377M Dec/2025
Grifols EUR 1.32B 22.75M Sep/2025
Halozyme Therapeutics USD 102.15M 29.14M Dec/2025
Incyte USD 121.18M 22.18M Dec/2025
Ionis Pharmaceuticals USD 8M 5.66M Dec/2025
Ironwood Pharmaceuticals USD 29.83M 560K Sep/2024
Karyopharm Therapeutics USD 37.43M 2.41M Sep/2024
MacroGenics USD 44.3M 5.4M Sep/2025
Merck USD 3.32B 531M Dec/2025
Nektar Therapeutics USD 4.43M 5.3M Sep/2024
Neurocrine Biosciences USD 17.6M 246.4M Dec/2025
Novartis USD 3.54B 217M Sep/2025
Pfizer USD 6.29B 2.12B Dec/2025
Roche Holding CHF 8.48B 4.61B Dec/2025
Sarepta Therapeutics USD 399.38M 247.93M Dec/2025
Takeda JPY 401.15B 184.07B Dec/2025
Teva Pharmaceutical Industries USD 2.06B 120M Dec/2025
Xencor USD 61.66M 50.95M Jun/2025